Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Johnson and Johnson
Mallinckrodt
Colorcon
Baxter

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Succimer - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for succimer and what is the scope of patent protection?

Succimer is the generic ingredient in one branded drug marketed by Recordati Rare and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for succimer. One supplier is listed for this compound.

Recent Clinical Trials for succimer

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 2
National Cancer Institute (NCI)Phase 2
FDA Office of Orphan Products DevelopmentPhase 2/Phase 3

See all succimer clinical trials

Pharmacology for succimer
Drug ClassLead Chelator
Mechanism of ActionLead Chelating Activity
Medical Subject Heading (MeSH) Categories for succimer
Synonyms for succimer
(2R,3S)-2,3-dimercaptosuccinic acid
(2R,3S)-2,3-disulfanylsuccinic acid
(2R,3S)-rel-2,3-Dimercaptosuccinic acid
(2S,3R)-2,3-bis(sulfanyl)butanedioic acid
(3S,2R)-2,3-disulfanylbutanedioic acid
(R*,S*)-2,3-Dimercaptobutanedioic acid
2,3-Dithio-meso-tartaric acid
2418-14-6 (parent cpd)
3-03-00-01033 (Beilstein Handbook Reference)
304-55-2
304D552
AC-1366
AC1MC4R8
AJ-45793
AK161810
AKOS015892684
API0004249
APRD01236 (Drugbankr
AX8137528
BC219408
BRD-K88701661-001-01-1
BRN 1725150
Butanedioic acid, 2,3-dimercapto-, (2R,3S)-rel-
Butanedioic acid, 2,3-dimercapto-, (R*,S*)-
C07598
C4H6O4S2
CCG-214189
CD-226
CHEBI:63623
CHEMBL1201073
Chemet
Chemet (TN)
CS-0013797
D00572
D1722
DB00566
Dim-sa
Dimercaptosuccinic acid
DMSA
DS-7410
DTXSID1023601
DX1U2629QE
EINECS 206-155-2
FCH3467898
HSDB 6783
HY-B1768
Jsp005747
KS-00000GJ8
LS-147428
meso-2,3-Dimercaptobernsteinsaeure
meso-2,3-Dimercaptobernsteinsaure
meso-2,3-Dimercaptosuccinic acid
meso-2,3-Dimercaptosuccinic acid, ~98%
meso-2,3-Dimercaptosuccinic acid, 98%
meso-Dimercaptosuccinic acid
MFCD00064799
MolPort-003-666-563
Q-201748
Ro 1-7977
Ro-1-7977
SBB065802
SCHEMBL14941
SPECTRUM1505007
ST24034020
ST51007322
Succimer (USAN/INN)
Succimer [USAN:INN:BAN]
Succimero
Succimero [INN-Spanish]
Succimerum
Succimerum [INN-Latin]
Succinic acid, 2,3-dimercapto-, meso-
Tin Dimercaptosuccinate
UNII-4S9JU7XF01 component ACTRVOBWPAIOHC-XIXRPRMCSA-N
UNII-DX1U2629QE
ZINC3831475

US Patents and Regulatory Information for succimer

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare CHEMET succimer CAPSULE;ORAL 019998-002 Jan 30, 1991 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Boehringer Ingelheim
Baxter
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.